Clinical and Life Sciences · 25 September 2026 to 25 September 2026 · 1 headlines · STAT
STAT Plus: Alkermes’ orexin agonist shows potential to treat ADHD in early-stage trial
Alkermes' orexin agonist demonstrated potential as a treatment for ADHD in an early-stage clinical trial.